Barclays’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-117,000
| Closed | -$3.23M | – | 4963 |
|
|
2021
Q4 | $3.23M | Sell |
117,000
-91,300
| -44% | -$2.44M | ﹤0.01% | 2039 |
|
|
2021
Q3 | $5.8M | Buy |
+208,300
| New | +$5.91M | ﹤0.01% | 1528 |
|
|
2021
Q1 | – | Sell |
-100
| Closed | -$2K | – | 4699 |
|
|
2020
Q4 | $2K | Sell |
100
-1,900
| -95% | -$35.4K | ﹤0.01% | 4812 |
|
|
2020
Q3 | $31K | Sell |
2,000
-30,400
| -94% | -$524K | ﹤0.01% | 4783 |
|
|
2020
Q2 | $593K | Sell |
32,400
-319,700
| -91% | -$5.63M | ﹤0.01% | 3199 |
|
|
2020
Q1 | $5.46M | Sell |
352,100
-305,400
| -46% | -$7.36M | ﹤0.01% | 1392 |
|
|
2019
Q4 | $19.7M | Buy |
657,500
+248,600
| +61% | +$6.46M | 0.01% | 963 |
|
|
2019
Q3 | $8.93M | Sell |
408,900
-218,600
| -35% | -$5M | 0.01% | 1370 |
|
|
2019
Q2 | $15.8M | Buy |
627,500
+74,500
| +13% | +$1.77M | 0.01% | 1062 |
|
|
2019
Q1 | $13.7M | Sell |
553,000
-447,800
| -45% | -$10.7M | 0.01% | 1042 |
|
|
2018
Q4 | $18.5M | Buy |
1,000,800
+71,800
| +8% | +$1.71M | 0.01% | 789 |
|
|
2018
Q3 | $23.8M | Buy |
929,000
+164,300
| +21% | +$3.76M | 0.02% | 753 |
|
|
2018
Q2 | $17.8M | Sell |
764,700
-247,400
| -24% | -$5.12M | 0.02% | 855 |
|
|
2018
Q1 | $16.1M | Sell |
1,012,100
-1,438,900
| -59% | -$26.8M | 0.01% | 952 |
|
|
2017
Q4 | $50.9M | Buy |
2,451,000
+1,141,400
| +87% | +$18.1M | 0.04% | 413 |
|
|
2017
Q3 | $18.8M | Sell |
1,309,600
-500,100
| -28% | -$7.56M | 0.02% | 697 |
|
|
2017
Q2 | $31.3M | Sell |
1,809,700
-657,700
| -27% | -$7.88M | 0.03% | 423 |
|
|
2017
Q1 | $27.2M | Sell |
2,467,400
-127,800
| -5% | -$1.76M | 0.03% | 442 |
|
|
2016
Q4 | $37.7M | Buy |
2,595,200
+115,400
| +5% | +$2.12M | 0.04% | 345 |
|
|
2016
Q3 | $60.9M | Buy |
2,479,800
+22,100
| +0.9% | +$572K | 0.07% | 217 |
|
|
2016
Q2 | $49.5M | Buy |
2,457,700
+1,309,700
| +114% | +$37.1M | 0.06% | 259 |
|
|
2016
Q1 | $29.8M | Buy |
1,148,000
+8,400
| +0.7% | +$621K | 0.05% | 357 |
|
|
2015
Q4 | $115M | Buy |
1,139,600
+308,200
| +37% | +$34.6M | 0.14% | 124 |
|
|
2015
Q3 | $148M | Sell |
831,400
-38,500
| -4% | -$8.98M | 0.18% | 88 |
|
|
2015
Q2 | $193M | Sell |
869,900
-725,500
| -45% | -$161M | 0.22% | 58 |
|
|
2015
Q1 | $316M | Buy |
1,595,400
+434,900
| +37% | +$77.1M | 0.36% | 26 |
|
|
2014
Q4 | $166M | Buy |
1,160,500
+536,200
| +86% | +$72.1M | 0.16% | 94 |
|
|
2014
Q3 | $81.8M | Buy |
624,300
+207,000
| +50% | +$24.7M | 0.08% | 200 |
|
|
2014
Q2 | $52.6M | Sell |
417,300
-861,500
| -67% | -$110M | 0.06% | 295 |
|
|
2014
Q1 | $168M | Buy |
1,278,800
+255,700
| +25% | +$35M | 0.19% | 84 |
|
|
2013
Q4 | $120M | Sell |
1,023,100
-306,000
| -23% | -$33.5M | 0.12% | 127 |
|
|
2013
Q3 | $138M | Sell |
1,329,100
-167,200
| -11% | -$16.3M | 0.17% | 85 |
|
|
2013
Q2 | $129M | Buy |
+1,496,300
| New | +$118M | 0.16% | 84 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Barclays's BHC Position: Q1 2026 in Review
Barclays increased its Bausch Health (BHC) stake by 520% in Q1 2026, buying an estimated $621K and bringing the position to 123,783 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.
Barclays first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.24B in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Barclays held 123,783 shares of Bausch Health worth $668K as of Q1 2026.
- Barclays bought 103,818 Bausch Health shares in Q1 2026, an estimated $621K.
- Bausch Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3003 holding.
- Barclays first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
- Barclays's Bausch Health position peaked at $1.24B in Q4 2014.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.